Exclusive: Pain-care specialist agrees to testify against Purdue, other drug makers - court documents

Brasil Notícia Notícia

Exclusive: Pain-care specialist agrees to testify against Purdue, other drug makers - court documents
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 Reuters
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 97%

EXCLUSIVE: A physician ally of Purdue Pharma has agreed to testify against the OxyContin maker and other drug companies, newly disclosed court records show

- A physician ally of Purdue Pharma LP whose views helped drive the explosive growth in the use of addictive pain relievers for common aches and pains in the United States has agreed to testify against the OxyContin maker and other drug companies, newly disclosed court records show.

But Portenoy began talking to plaintiffs’ lawyers as early as January 2018 and later struck a deal with the plaintiffs to serve as a cooperating witness, the records show. In exchange for his dismissal from the suits, Portenoy provided the plaintiffs with documentation of opioid makers’ payments to him over the years, as well as a 36-page declaration that lays out what he would say on the witness stand.

Portenoy could not be reached for comment. His lawyer did not immediately respond to an email seeking comment. Portenoy, who has held leadership positions at Memorial Sloan-Kettering Cancer Center and Mount Sinai Beth Israel, was among the first physicians to espouse opioids as an option for the treatment of chronic pain, a condition that afflicts tens of millions of Americans, in medical journal articles published in the 1980s and 1990s. Later, he shared his views with physicians at conferences and in training videos sponsored by opioid makers, he said in the declaration.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Reuters /  🏆 2. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Amid the opioid scandal, what next for Purdue Pharma and the Sackler family?Amid the opioid scandal, what next for Purdue Pharma and the Sackler family?Our weekly podcast on the markets, the economy and the world of business
Consulte Mais informação »

Purdue's Sackler family fights 'inflammatory' Massachusetts opioid casePurdue's Sackler family fights 'inflammatory' Massachusetts opioid caseMembers of the Sackler family behind OxyContin maker Purdue Pharma LP have asked...
Consulte Mais informação »

Purdue Pharma’s Sackler family wants opioid lawsuit thrown outPurdue Pharma’s Sackler family wants opioid lawsuit thrown outThe Sackler family, which controls OxyContin maker Purdue Pharma, says a Massachusetts lawsuit that alleges Purdue fueled the opioid epidemic relies on false assertions.
Consulte Mais informação »

Members of Purdue Pharma’s Sackler Family Leave Nonprofit BoardMembers of Purdue Pharma’s Sackler Family Leave Nonprofit BoardCertain members of the Sackler family, which owns OxyContin-maker Purdue Pharma, are leaving governing boards of prominent nonprofit organizations as they face scrutiny for their alleged role in sparking the nation’s opioid crisis.
Consulte Mais informação »

March Madness: Was this the best Elite Eight weekend ever?March Madness: Was this the best Elite Eight weekend ever?Two OT games, including an instant classic Virginia-Purdue contest, combined with Michigan State's upset of Duke made for one epic weekend.
Consulte Mais informação »

2 drug giants are feuding over a highly successful new migraine drug, and court documents reveal how profitable the $10 billion market could be2 drug giants are feuding over a highly successful new migraine drug, and court documents reveal how profitable the $10 billion market could beTwo drugmakers, Amgen and Novartis, have worked together for years on a new type of cutting-edge migraine drug, Aimovig.
Consulte Mais informação »

Monster energy drink maker expands lawsuit against rival BangMonster energy drink maker expands lawsuit against rival BangMonster energy drink's maker says fast-growing rival Bang is engaging in false advertising and unfair competition, among other claims.
Consulte Mais informação »



Render Time: 2025-03-04 08:18:05